BRAENDER LORI J
SEC CIK 1752955 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | SVP, GC | 231.0K | $13.2K | $167.2K | 10 | 2022-06-08 | 2026-05-07 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 16:35 | 2026-05-07 | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | Corp. Sec | F - Tax | $4.23 | -135.7K | 231.0K | -37% | -$574.0K | |
| 2026-05-07 17:31 | 2026-05-05 | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | Corp. Sec | F - Tax | $4.18 | -76.1K | 366.7K | -17% | -$318.3K | |
| D | 2026-03-11 | 2026-03-10 | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | CLO | S - Sale | $4.17 | -40.1K | 442.9K | -8% | -$167.2K |
| D | 2026-03-11 | 2026-03-09 | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | CLO | A - Grant | $0.00 | +80.0K | 483.0K | +20% | $0 |
| D | 2025-03-11 | 2025-03-07 | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | CLO | A - Grant | $0.00 | +110.0K | 423.2K | +35% | $0 |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | CLO | F - Tax | $2.65 | -20.2K | 413.6K | -5% | -$53.7K |
| 2024-03-12 | 2024-03-09 | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | SVP, GC | F - Tax | $4.88 | -10.5K | 313.2K | -3% | -$51.4K | |
| D | 2024-03-11 | 2024-03-07 | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | SVP, GC | A - Grant | $0.00 | +135.0K | 323.8K | +72% | $0 |
| 2023-03-09 | 2023-03-09 | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | SVP, GC | A - Grant | $0.00 | +150.0K | 188.8K | +387% | $0 | |
| D | 2022-06-10 | 2022-06-08 | AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | GC | P - Purchase | $0.96 | +13.8K | 38.8K | +55% | +$13.2K |
Purchase Sale Sale after option exercise All abbreviations